For example, the hypermethylation of the IGFBP3 promoter, and upregulation of forkhead box F1 (FOXF1) expression was found to trigger resistance to cisplatin and the acquisition of cancer stem cell (CSC)-like phenotypes in NSCLC cells [67]. Here, FOXF1 is linked to cancer.